GlobalIPNews

Sign Up
|
Login
|

18:14:34 Tue 09 Jun 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Tianjin University

(29)

Shanghai Jiao Tong Univer

(28)

(18)

(14)

Eli Lilly and Company

(10)

Hoffmann La Roche

(10)

Jiangsu Hengrui Pharmaceu

(10)

Genzyme Corporation

(7)

China Pharmaceutical Univ

(6)

(6)

Kumquat Biosciences

(6)

Boehringer Ingelheim Inte

(5)

Meilan Hangzhou Pharmaceu

(5)

(5)

Regeneron Pharmaceuticals

(5)

Suzhou Ribo Life Science

(5)

Tianjin University of Sci

(5)

Zhejiang Yulong Pharmaceu

(5)

(4)

Bristol Myers Squibb

(4)

Guangdong Fapon Biopharma

(4)

Guangdong Power Grid; Sha

(4)

Harbin Medical University

(4)

Nuclear Power Institute o

(4)

Otsuka Pharmaceutical

(4)

Revolution Medicines

(4)

Ruijin Hospital Shanghai

(4)

Shenzhen Salubris Pharmac

(4)

Spirit Jinyu Biological P

(4)

Topfond Pharma Co Ltd

(4)

Zhejiang University

(4)

Adlai Nortye Biopharma

(3)

Anomed Singapore Pte Ltd;

(3)

(3)

Chia Tai Tianqing Pharmac

(3)

Cisen Pharmaceutical Co L

(3)

Fundacion Instituto De In

(3)

(3)

(3)

Guoke Ningbo Life And Hea

(3)

Gwangju Inst Of Science A

(3)

Hangzhou Zhongmei Huadong

(3)

Hebei Longhai Pharmaceuti

(3)

Hoffmann-La Roche

(3)

Hubei Gedian Humanwell Ph

(3)

Jewim Pharmaceutical (Sha

(3)

Jiangsu 707 Natural Pharm

(3)

Jiangsu Dongkang Biomedic

(3)

Persio Pharmaceuticals In

(3)

Shandong Chuangxin Pharma

(3)

Shandong Institute of Med

(3)

Shandong Linuo Pharmaceut

(3)

Shenzhen Rhegen Biotechno

(3)

Sichuan Kelun-Biotech Bio

(3)

Sichuan Neo Green Pharmac

(3)

State Grid Shanghai Munic

(3)

Tianjin University of Com

(3)

Veradermics Incorporated

(3)

Wuxi Fortune Pharmaceutic

(3)

Wuxi Jiyu Shanhe Pharmace

(3)

Xizang Haisco Pharmaceuti

(3)

Zhejiang Nuode Pharmaceut

(3)

Amylyx Pharmaceuticals

(2)

Anhui University of Chine

(2)

Ascletis Pharma China Co

(2)

Astellas Pharma

(2)

Beijing Hospital

(2)

Beijing Sun Novo Pharmace

(2)

(2)

Boehringer Ingelheim Int

(2)

Boehringer Ingelheim Vetm

(2)

Cedilla Therapeutics

(2)

Changchun Genescience Pha

(2)

Changchun University of T

(2)

Chengdu Paiweisi Smart Me

(2)

China Academy of Chinese

(2)

China Chemical & Pharmace

(2)

China Resources Finance N

(2)

Chongqing Guochengtang Ph

(2)

Chongqing Xinongdakexin A

(2)

Cls Therapeutics Llc

(2)

Crinetics Pharmaceuticals

(2)

(2)

Dalian Polytechnic Univer

(2)

Davis Andrew Peter

(2)

Dominic Schiller [gb]; Ge

(2)

ENSEM Therapeutics

(2)

(2)

Fuzhou Neptunus Fuyao Pha

(2)

Guangdong Lanyu Biotechno

(2)

Guangdong University of T

(2)

Guangdong Yifang Pharmace

(2)

Haisco Pharmaceutical Gro

(2)

Hangzhou Fst Pharmaceutic

(2)

Heilongjiang University o

(2)

Hoffmann La Roche [ch]; R

(2)

Hubei Shuangxing Pharmace

(2)

Inflamed Pharma Gmbh

(2)

Institute Military Medici

(2)

Intas Pharmaceuticals

(2)

(2)

Janssen Pharmaceutica

(2)

Jiangnan University

(2)

Jiangsu Aidea Pharmaceuti

(2)

Jiangsu Chenxing Pharmace

(2)

Jiangsu Sino Biopharma Co

(2)

Jiangsu Zhongbang Pharmac

(2)

Jiangxi Jinding Pharmaceu

(2)

Jiangxi Tianxin Pharmaceu

(2)

Jiaozuo Furuitang Pharmac

(2)

Koerber Pharma Inspection

(2)

Korea Inst Of Science And

(2)

Korea University Research

(2)

Lanzhou University

(2)

Merck Sharp & Dohme

(2)

(2)

Morphic Therapeutic

(2)

Nanjing Children\'s Hospi

(2)

Nanjing Leizheng Pharmace

(2)

Nanjing Normal University

(2)

Nanjing Puruida Pharmaceu

(2)

Nanjing Well Pharmaceutic

(2)

(2)

Peking University First H

(2)

(2)

Qilu Pharmaceutical

(2)

Qingdao Baheal Pharmaceut

(2)

Qualicaps Co Ltd

(2)

Renji Hospital Shanghai J

(2)

Ribocure Pharmaceuticals

(2)

Roche Diagnostics Gmbh [d

(2)

Shaanxi Kanghe Li Feng Bi

(2)

Shaanxi University of Chi

(2)

Shandong Anhong Pharmaceu

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Senhui Medicine

(2)

Shanghai Tongjin Stem Cel

(2)

Shanghai Yaxin Biotechnol

(2)

Shanghai Yingli Pharmaceu

(2)

Shenyang Pharmaceutical U

(2)

Shenzhen Ruiji Biotechnol

(2)

Shijiazhuang Gerui Pharma

(2)

(2)

Solve Therapeutics

(2)

Soochow University

(2)

Sun Yat Sen University Sh

(2)

Sun Yat-sen University

(2)

Syndax Pharmaceuticals In

(2)

Takeda Pharmaceuticals

(2)

The Broad Inst Inc [us];

(2)

Tianjin University of Tec

(2)

Tianjin University of Tra

(2)

(2)

Univ Ewha Ind Collaborati

(2)

Vertex Pharmaceuticals

(2)

Wuhan Createrna Science a

(2)

Wuhan Guanggu Zhongyuan P

(2)

Wuxi Origene Bio Tech Co

(2)

Xi\'an International Medi

(2)

Xinhua Hospital affiliate

(2)

Yichang Humanwell Pharmac

(2)

ADARx Pharmaceuticals

(1)

ADS Therapeutics

(1)

(1)

Aarhus University

(1)

Abbisko Pharmaceuticals C

(1)

Ablexa Pharmaceuticals In

(1)

Abtis Co Ltd [kr]; Resear

(1)

Academia Sinica

(1)

Acadia Pharmaceuticals

(1)

Acerand Therapeutics (Hon

(1)

Aconcagua Bio Inc

(1)

Acrotech Biopharma Inc

(1)

Acurastem Incorporated

(1)

Acurx Pharmaceuticals Inc

(1)

Adienne Pharma & Biotech

(1)

Adlai Nortye Biopharma; A

(1)

Affiliated Hospital Of Sh

(1)

Affiliated Hospital Xuzho

(1)

Affiliated Hospital of Na

(1)

Affiliated Hospital of Ya

(1)

Agency for Science, Techn

(1)

(1)

Aitemei Suzhou Pharmaceut

(1)

Aivo Biosciences Inc

(1)

Aiweituo Jiangsu Pharmace

(1)

Aiweituo Jiangsu Pharmace

(1)

Akava Therapeutics Inc [u

(1)

(1)

Alexia Therapeutics

(1)

(1)

Alkermes Pharma Ireland

(1)

Allergan Pharmaceuticals

(1)

Altin Biosciences Corp

(1)

Altmedical Co Ltd [kr]; D

(1)

(1)

Ambio Life Sciences Inc

(1)

Amgen Inc [us]; Revolutio

(1)

Amunix Pharmaceuticals

(1)

Amytrx Therapeutics Inc

(1)

Anavex Life Sciences

(1)

(1)

Anglii Tianjin Biotechnol

(1)

Anhui Double Crane Pharma

(1)

Anhui Institute of Inform

(1)

Anhui Jiuxin Pharmaceutic

(1)

Anhui Longyibaicao Biolog

(1)

Anhui Medical University

(1)

Anhui Nuoerkang Pharmaceu

(1)

Anhui Ruiqi Pharmaceutica

(1)

Anhui Xinshiji Pharmaceut

(1)

Anhui Yipuke Medical Tech

(1)

Apellis Pharmaceuticals

(1)

Apogee Therapeutics Inc

(1)

Applied Res Using Omic Sc

(1)

Apstem Therapeutics Inc

(1)

Ariel Scientific Innovati

(1)

Arizona Board of Regents

(1)

Aronora Inc [us]; Oregon

(1)

Arromax Pharmatech Co Ltd

(1)

Arrowhead Res Corporation

(1)

Arvinas Operations

(1)

Ascentage Pharma Suzhou C

(1)

Ascentawits Pharmaceutica

(1)

Asr Technologies Co Ltd;

(1)

Astelza Therapeutics Inc

(1)

Astrocyte Pharmaceuticals

(1)

(1)

Atossa Therapeutics

(1)

Atreya Innovations Pvt Lt

(1)

Auspex Pharmaceuticals Ll

(1)

Austar Pharmaceutical Equ

(1)

Azurity Pharmaceuticals

(1)

(1)

(1)

(1)

Bacto Pharma Ltd

(1)

Baisite Pharmaceutical Gu

(1)

Bashanhong Beijing Pharma

(1)

Bayer Animal Health

(1)

Beijing Academy of Scienc

(1)

Beijing Cancer Hospital;

(1)

Beijing Chest Hospital Ca

(1)

Beijing Continent Pharmac

(1)

Beijing Double Crane Phar

(1)

Beijing Gengshi Co Ltd

(1)

Beijing Hengcheng Huiren

(1)

Beijing Inst Of Tradition

(1)

Beijing Kangchuanglian Bi

(1)

Beijing Northland Biotech

(1)

Beijing Proteome Res Cent

(1)

Beijing Tcmages Pharmaceu

(1)

Beijing Tianheng Pharmace

(1)

Beijing University of Che

(1)

Beijing University of Chi

(1)

Beijing Xianhan Guoke Bio

(1)

Beijing Xuanjingrui Pharm

(1)

Beijing Yunpeng Pengcheng

(1)

Beijing Zaiqing Biotechno

(1)

Bencaofangtang Traditiona

(1)

Bened Biomedical Co Ltd

(1)

Bide Pharmatech Co Ltd

(1)

Big Health Res Institute

(1)

Big Health Res Institute

(1)

Bijie Traditional Chinese

(1)

(1)

Biocells Beijing Biotechn

(1)

Biocytogen Pharmaceutical

(1)

Biogen Ma Inc [us]; Ginkg

(1)

Biolexis Therapeutics

(1)

Biomedical Lab S R L

(1)

Biomedical Res Group Inc

(1)

Biper Therapeutics Sas [f

(1)

Bluebable Pharmaceutical

(1)

Bluerock Therapeutics Lp

(1)

Bo Hui Biotech Co Ltd

(1)

Boehringer Ingelheim Anim

(1)

Boehringer Ingelheim Int

(1)

Boehringer Ingelheim Inte

(1)

Boehringer Ingelheim Vetm

(1)

Bormioli Pharma S P A

(1)

Brain Check Medical Llc

(1)

Butura Christian

(1)

C/o Animal Microbiome Ana

(1)

CSPC Zhongqi Pharmaceutic

(1)

(1)

(1)

California Inst Of Techno

(1)

Cambridge Allergy Ltd

(1)

Capital University of Med

(1)

Capsugel Belgium Nv

(1)

Captor Therapeutics

(1)

Cardiol Therapeutics Inc

(1)

Cardurion Pharmaceuticals

(1)

Carmot Therapeutics

(1)

Carmot Therapeutics Inc [

(1)

Cedars Sinai Medical Cent

(1)

Cell Therapy And Tech S A

(1)

Cella Therapeutics Llc

(1)

Central South University

(1)

Central South University;

(1)

Centre For Chinese Herbal

(1)

Centrexion Therapeutics

(1)

Centro Di Riferimento Onc

(1)

Cerevel Therapeutics Llc

(1)

Cf Pharmatech Inc

(1)

Cg Pharmaceuticals Inc

(1)

(1)

Changchun Lanjiang Pharma

(1)

Changchun University of C

(1)

Changshan Conjuchem Biolo

(1)

Changzhou Bohiv Pharmaceu

(1)

Changzhou Hongmeng Bio Te

(1)

Changzhou Jiade Pharmaceu

(1)

Changzhou No 4 Pharmaceut

(1)

Changzhou Shenghui Pharma

(1)

Changzhou Sunlight Pharm

(1)

Changzhou University

(1)

Chemical Research Institu

(1)

(1)

Chengdu Anlite Pharmaceut

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu Greenpure Biophar

(1)

Chengdu Hyperway Pharmace

(1)

Chengdu Jiuzhitang Jindin

(1)

Chengdu Medical College

(1)

Chengdu New Radiomedicine

(1)

Chengdu Organic Chemistry

(1)

Chengdu Shibeikang Biomed

(1)

Chengdu Shuode Pharmaceut

(1)

Chengdu University of Tra

(1)

Chengdu Yangtian Wanying

(1)

Chiesi Farmaceutici

(1)

China Nat Offshore Oil Co

(1)

China Resources Sanjiu Me

(1)

China Union Chempharma Su

(1)

China West Normal Univers

(1)

Chong Kun Dang Pharmaceut

(1)

Chongqing Kerui Pharmaceu

(1)

Chongqing Medical Univers

(1)

Chongqing Pharscin Pharma

(1)

Chongqing Research Instit

(1)

Chongqing Traditional Chi

(1)

Chongqing University

(1)

Chongqing University of P

(1)

Chongqing University of S

(1)

Chongqing University of T

(1)

Chongqing Xiukang Traditi

(1)

Chongqing Yaogu Pharmaceu

(1)

Chugai Pharmaceutical

(1)

(1)

Circum Medtech Pharma

(1)

City University of Hong K

(1)

Clearside Biomedical Inc

(1)

Click Therapeutics

(1)

Coherent Biopharma, Suzho

(1)

Comanche Biopharma Inc

(1)

Concaro Therapeutics Inc

(1)

Contex Biosciences Usa In

(1)

Convalife Pharmaceuticals

(1)

Convelo Therapeutics Inc

(1)

Cool Pharmaceuticals Dev

(1)

Cosa Group Gmbh

(1)

Council of Scientific & I

(1)

Cross Walker Therapeutics

(1)

Cspc Baike Shandong Bio P

(1)

Curaem Pharmaceuticals Pt

(1)

Curon Biopharmaceutical S

(1)

Cyclacel Pharmaceuticals

(1)

Daan Biotherapeutics Co L

(1)

Daewoong Pharmaceutical

(1)

Daiichi Sankyo Healthcare

(1)

Dalian Shuangpeng Pharmac

(1)

Dalian Zhen Ao Pharmaceut

(1)

(1)

Dana Farber Cancer Inst I

(1)

Dangshan County Peoples H

(1)

(1)

Deep Apple Therapeutics I

(1)

Demarest Stephen [us]; Ka

(1)

(1)

Design Therapeutics

(1)

Dewpoint Therapeutics

(1)

Dexing City Chinese Medic

(1)

Dexon Pharmaceuticals Inc

(1)

Dezhou Jinghua Pharmaceut

(1)

Dezhou Kinsana Pharmaceut

(1)

Dezhou Lanli Biotechnolog

(1)

Disarm Therapeutics

(1)

Dongfang Hospital Beijing

(1)

Dongying Pingming Pharmac

(1)

Droplet Genomics Uab

(1)

Duality Biologics Suzhou

(1)

Duality Biologics Suzhou

(1)

Dxm Pharmaceutical Inc

(1)

Dyno Therapeutics

(1)

(1)

East China Normal Univers

(1)

East China University of

(1)

Efx Medical Tech Pty Ltd

(1)

Eisbach Bio Gmbh

(1)

Elanco Animal Health

(1)

Electric Power Res Inst S

(1)

Electric Power Science Re

(1)

Eleos Pharmaceuticals Inc

(1)

Eli Lilly And Co

(1)

Emergent Biodefense Opera

(1)

Emory University

(1)

Enanta Pharmaceuticals

(1)

Endo Ventures Ltd [ie]; E

(1)

Eonvelab Co Ltd

(1)

Epirium Bio Inc

(1)

Epitech Group S P A

(1)

Erchu of China Railway Tu

(1)

Espervita Therapeutics

(1)

Eubulus Biotherapeutics H

(1)

Evans David [ca]; Noyce R

(1)

(1)

(1)

Eye Hospital of China Aca

(1)

Fasikl Incorporated [us];

(1)

(1)

Firat Univ Rektorlugu

(1)

Firmenich & Cie

(1)

First Affiliated Hospital

(1)

Flagship Pioneering Innov

(1)

(1)

Foghorn Therapeutics

(1)

Forcast Orthopedics Inc

(1)

Fortune Res & Development

(1)

Foshan Power Supply Burea

(1)

Fourth Hospital of Hebei

(1)

Fresenius Kabi Oncology L

(1)

Fujian Leephick Pharmaceu

(1)

Fusion Pharmaceuticals

(1)

Fuzhou Zhixin Future Elec

(1)

(1)

GM Global Tech Operations

(1)

Gan & Lee Pharmaceuticals

(1)

Gansu Hengbo Tech Co Ltd

(1)

Gansu Institute for Drug

(1)

Gansu Pharmaceutical Grou

(1)

(1)

(1)

Genentech Inc [us]; Hoffm

(1)

General Biological Anhui

(1)

Gesynta Pharma Ab

(1)

GlaxoSmithKline Intellect

(1)

Glaxosmithkline Biologica

(1)

(1)

Golden Health Guangdong B

(1)

Groovy Medicine Hangzhou

(1)

Guangdong B&h Health Care

(1)

Guangdong HEC Pharmaceuti

(1)

Guangdong Haikaipu New Ph

(1)

Guangdong Huanan Pharmacy

(1)

Guangdong Muhou Pharmaceu

(1)

Guangdong Nanguo Pharmace

(1)

Guangdong Pharmaceutical

(1)

Guangdong Provincial Labo

(1)

Guangdong Provincial Peop

(1)

Guangdong Raynovent Biote

(1)

Guangdong Ziying Kangyan

(1)

Guanghan Hospital of Trad

(1)

Guangxi Baiyunshan Yingka

(1)

Guangxi Inst Chinese Medi

(1)

Guangxi Pingguo Runfeng C

(1)

Guangxi University of Chi

(1)

Guangxi Wuzhou Pharm Grou

(1)

Guangxi Zhuang Autonomous

(1)

Guangxi Zhuangyuan Pharma

(1)

Guangzhou Congen Pharmate

(1)

Guangzhou Daguang Pharmac

(1)

Guangzhou Hanmay Cosmetic

(1)

Guangzhou Hutong Youwu Bi

(1)

Guangzhou Jinmanli Pharma

(1)

Guangzhou Jintai Life Tec

(1)

Guangzhou Junmu Biotechno

(1)

Guangzhou Magpie Pharmace

(1)

Guangzhou Medical Univers

(1)

Guangzhou Medical Univers

(1)

Guangzhou Medical Univers

(1)

Guangzhou Medical Univers

(1)

Guangzhou National Labora

(1)

Guangzhou Novaken Pharm C

(1)

Guangzhou Soyoang Biotech

(1)

Guangzhou Trojan Pharmate

(1)

Guangzhou University of C

(1)

Guangzhou Vocational and

(1)

Guangzhou Zhongda Furui M

(1)

Guhan Traditional Chinese

(1)

Guizhou Beijixing Pharmac

(1)

Guizhou Natural Product R

(1)

Guizhou Nursing Vocationa

(1)

Guizhou Ruihe Pharmaceuti

(1)

Guizhou Weikang Zifan Pha

(1)

(1)

Guosheng Zhiku Culture De

(1)

(1)

Hadasit Medical Res Servi

(1)

Hainan Jiajiakang Medical

(1)

Hainan University

(1)

(1)

Hamada Katsuyuki

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou Cixing Tech Co L

(1)

Hangzhou Dinghe Intellige

(1)

Hangzhou Enhe Biotechnolo

(1)

Hangzhou Innogate Pharma

(1)

Hangzhou Shengzhitang Bio

(1)

Hangzhou Tiankang Chuangj

(1)

Hangzhou Tongjuntang Biol

(1)

Hangzhou Yiwan Intelligen

(1)

Hangzhou Zhongmei Huadong

(1)

Hanmi Fine Chemical

(1)

Hanmi Pharmaceutical

(1)

Harbin Pharmaceutical Gro

(1)

(1)

Health Ai Holdings Ltd

(1)

Hebei Kaiwei Hengcheng Ph

(1)

Hebei Kangbo Pharmaceutic

(1)

Hebei Reproductive Health

(1)

Hefei Institute Technolog

(1)

Hefei Jingke Biotechnolog

(1)

Hefei Normal University

(1)

Heilongjiang Sengong Trad

(1)

Heilongjiang University

(1)

Heilongjiang University;

(1)

Helmholz Zentrum Muenchen

(1)

Henan Academy of Medical

(1)

Henan Agricultural Univ [

(1)

Henan Nuomei Pharmaceutic

(1)

Henan Provincial Eye Hosp

(1)

Henan Univ Of Medicine

(1)

Henan University of Chine

(1)

Henan Xiangyu Medical Equ

(1)

Herun Ruikang Shanghai Bi

(1)

Highfield Biopharmaceutic

(1)

Hisamitsu Pharmaceutical

(1)

Hoffmann La Roche [ch]; H

(1)

Hoffmann La Roche [ch]; H

(1)

Huachuan Pharmaceutical C

(1)

Huazhong Pharmaceutical C

(1)

Hubei Bio Pharmaceutical

(1)

Hubei Changjiang Ruiyi Ph

(1)

Hubei Chuwei Pharmaceutic

(1)

Hubei Gedian Humanwell Ph

(1)

Hubei Gongtong Pharmaceut

(1)

Hubei Guangren Medicament

(1)

Hubei Hongyuan Pharmaceut

(1)

Hubei Ruihua Pharmaceutic

(1)

Hubei Shizhen Laboratory

(1)

Hubei University of Techn

(1)

Hubei Xili Pharmaceutical

(1)

Hubei Yixin Tianan Medica

(1)

Hubei Yuanhao Biotechnolo

(1)

Hudong-Zhonghua Shipbuild

(1)

Huizhou Huasheng Biotechn

(1)

Hunan Aikesong Health Man

(1)

Hunan Asidikang Pharmaceu

(1)

Hunan Chunkehui Tradition

(1)

Hunan Huize Bio Pharmaceu

(1)

Hunan Juxiangtang Biologi

(1)

Hunan Meibai Biological P

(1)

Hunan Nonferrous Metals V

(1)

Hunan Province Xiangzhong

(1)

Hunan Runxing Pharmaceuti

(1)

Hunan Space Folding Inter

(1)

Hunan University of Chine

(1)

Hunan Yifang Tianjiang Ph

(1)

(1)

I P I Inworth Pharma Inc

(1)

IDEAYA Biosciences

(1)

Iambic Therapeutics

(1)

Ibio Inc [us]; Astralbio

(1)

Il Dong Pharmaceutical

(1)

(1)

(1)

Infinitus China Co Ltd

(1)

Inito Health Inc

(1)

Inner Mongolia Ringpu Dad

(1)

Innovent Biologics Suzhou

(1)

Innovent Biologics, Suzho

(1)

Insilico Medicine

(1)

Inst Basic Science [kr];

(1)

Inst Med Biotechnology Ca

(1)

Institut National De La S

(1)

Institute of Botany, Jian

(1)

Institute of Chinese Mate

(1)

Institute of Medicinal Pl

(1)

Insulet Corporation

(1)

Integrated DNA Technologi

(1)

Integrative Res Laborator

(1)

Intellia Therapeutics

(1)

International Business Ma

(1)

Intra-Cellular Therapies

(1)

Inventagelab Inc

(1)

(1)

Ipsen Biopharmaceuticals

(1)

(1)

Janssen Biotech

(1)

Jazz Pharmaceuticals Irel

(1)

Jazz Pharmaceuticals Rese

(1)

Jds Therapeutics Llc

(1)

Jem Therapeutics Inc

(1)

Ji Can Artificial Intelli

(1)

Jiang Chenghong

(1)

Jiangsu Agri Animal Husba

(1)

Jiangsu Demai Pharmaceuti

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Hansyn Pharmaceut

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hi Stone Pharmace

(1)

Jiangsu Huajing Molecular

(1)

Jiangsu Jiaerke Pharmaceu

(1)

Jiangsu Jingchan Pharmace

(1)

Jiangsu Jingsen Biologica

(1)

Jiangsu Lianhuan Pharmace

(1)

Jiangsu Nhwa Pharmaceutic

(1)

Jiangsu Provincial Xuzhou

(1)

Jiangsu Qunxin Powder Tec

(1)

Jiangsu Runan Pharmaceuti

(1)

Jiangsu Shenhou Pharmaceu

(1)

Jiangsu Simcere Medical D

(1)

Jiangsu Targetpharma Labo

(1)

Jiangsu University

(1)

Jiangsu Wangao Pharmaceut

(1)

Jiangsu Weiyao Informatio

(1)

Jiangsu Yahong Medicine S

(1)

Jiangsu Yahong Meditech C

(1)

Jiangxi Brother Pharmaceu

(1)

Jiangxi Changshuo Outdoor

(1)

Jiangxi Fangzhu Pharmaceu

(1)

Jiangxi Fuerxin Pharmaceu

(1)

Jiangxi Lushan Pharmaceut

(1)

Jiangxi Shimei Pharmaceut

(1)

Jiangxi Woran Pharmaceuti

(1)

Jiangxi Yuanbang Pharmace

(1)

Jiangxian Dev Zone Hongru

(1)

Jiangzhong Pharmaceutical

(1)

Jianmin Group Yekaitai Si

(1)

Jianmin Pharmaceutical Gr

(1)

Jianyang People\'s Hospit

(1)

Jiaxing Andicon Biotech C

(1)

Jiaxing Baimei Jihua Phar

(1)

Jilin Mufeng Pharmaceutic

(1)

Jilin Sihuan Aokang Pharm

(1)

Jilin University

(1)

Jilin Xiuzheng Pharmaceut

(1)

Jinan Kehui Pharmaceutica

(1)

Jinan University

(1)

Jining Shengtai Pharmaceu

(1)

(1)

Jiuzhou Pharmaceutical Ha

(1)

Jiuzhou Pharmaceutical Ha

(1)

Just Medical Equipment (T

(1)

K36 Therapeutics

(1)

Kaixing Life Tech Shangha

(1)

Kane Therapeutics Inc

(1)

Kangbaida (Sichuan) Biote

(1)

Kanglong Huacheng Ningbo

(1)

Karyopharm Therapeutics

(1)

Kasma Therapeutics Inc

(1)

Keli Italia Co Ltd

(1)

Kindeva Drug Delivery L P

(1)

Kinhoo Pharmaceutical Co

(1)

(1)

Km Biotherapeutics Ag

(1)

Korea Res Inst Bioscience

(1)

Kunming Keen Pharmaceutic

(1)

Kunming University of Sci

(1)

Kunshan Biogreen Tech Co

(1)

Kymera Therapeutics

(1)

Lantern Pharma Inc

(1)

Lanzhou Biotechnology Dev

(1)

Lanzhou Inst Of Husbandry

(1)

Lanzhou University Second

(1)

Leaderna Therapeutics Ltd

(1)

Legacy Healthcare (Switze

(1)

Leiyunshang Pharmaceutica

(1)

Leland Stanford Junior Un

(1)

Lepu Biopharma Co Ltd

(1)

Les Laboratoires Servier

(1)

Levena Suzhou Biopharma C

(1)

(1)

Lianying Yuezhi Scient In

(1)

Liaoning Inspection Exami

(1)

Liaoning Jiayu Tech Co Lt

(1)

Liaoning Youmi Future Tec

(1)

Lifemine Therapeutics Inc

(1)

Lilly Co Eli [us]; Nimbus

(1)

(1)

Lingyuan Pharmaceutical C

(1)

Linnane Pharma Ab

(1)

Linsol Co Ltd [kr]; Fourg

(1)

(1)

Lonch Group Ltd; Lonch Gr

(1)

Longhua Hospital Affiliat

(1)

Louis Dreyfus Co Ingredie

(1)

(1)

(1)

Ludwig Maximilians Univ T

(1)

Lukas Heil Betr Gmbh

(1)

Ma\'anshan People\'s Hosp

(1)

Mablink Bioscience [fr];

(1)

Madera Therapeutics Llc

(1)

Maia Pharmaceuticals Inc

(1)

(1)

Marshall Univ Research Co

(1)

Maxwell Biosciences

(1)

Mayinglong Great Health C

(1)

(1)

Medicis Pharmaceutical Co

(1)

(1)

Meisida Shanghai Pharmace

(1)

Meiye Biomedical Co Ltd;

(1)

Memorial Sloan Kettering

(1)

Memorial Sloan Kettering

(1)

Memorial Sloan Kettering

(1)

Merck Sharp & Dohme Llc [

(1)

Merck Sharp & Dohme Llc [

(1)

Merck Sharp & Dohme; Sich

(1)

Mingowood Pharmacal Llc

(1)

Mitsubishi Gas Chemical

(1)

Mitsubishi Tanabe Pharma

(1)

Mizugami Marketing Privat

(1)

Modernatx Inc [us]; Cytom

(1)

Momenta Pharmaceuticals

(1)

Monte Rosa Therapeutics

(1)

Motigenix Singapore Pte L

(1)

Myricx Pharma Ltd

(1)

Nacuity Pharmaceuticals I

(1)

Nadezhda Reproductive Sci

(1)

(1)

Nanjing Daoer Pharmaceuti

(1)

Nanjing Fanhai Pharmaceut

(1)

Nanjing Feilikang Pharmac

(1)

Nanjing Healthnice Pharma

(1)

Nanjing Jujiang Biotechno

(1)

Nanjing Kangzhou Pharmace

(1)

Nanjing Keluosi Biotechno

(1)

Nanjing Nutrabuilding Bio

(1)

Nanjing Reju Therapeutics

(1)

Nanjing Theranosta Inc

(1)

Nanjing University of Chi

(1)

Nanjing Weichuangyuan Pha

(1)

Nanjing Yinuo Pharmaceuti

(1)

Nanjing Zhongshan Pharm C

(1)

Nanning Hospital of Tradi

(1)

Nantong Haigine Pharma Te

(1)

Nantong Hospital of Tradi

(1)

Nantong Junyue Biopharmac

(1)

Nat Univ Corporation Okay

(1)

National Defense Medical

(1)

National Univ Corporation

(1)

(1)

Neulix Therapeutics Ab

(1)

Neurimmune Ag [ch]; Alexi

(1)

New York University

(1)

NewAmsterdam Pharma

(1)

Nexzol Pharma Inc

(1)

Nicox Sa [fr]; Fera Pharm

(1)

(1)

Ningbo Eye Hospital

(1)

Ningbo Institute of Mater

(1)

Ningbo Lianhe Photon Tech

(1)

Ningbo Shangwei Hi Tech C

(1)

Ningbo Traditional Chines

(1)

Ningbo University

(1)

Ningbo Yihe Medical Equip

(1)

Ningxia Kangtailong Chine

(1)

Ningxia Medical Universit

(1)

Ningxia Qiyuan Pharmaceut

(1)

Niuoushen Medical Shangha

(1)

(1)

(1)

North China University of

(1)

Northeast Electric Power

(1)

Northwest Normal Universi

(1)

Northwestern University

(1)

Novartis Ag [ch]; Astex T

(1)

Novartis Ag [ch]; Univers

(1)

Novilla Pharmaceuticals I

(1)

(1)

Npgs Guangdong Biotechnol

(1)

Nuclidium Ag [ch]; Univer

(1)

(1)

(1)

Nxera Pharma UK

(1)

(1)

(1)

Odesai Therapeutics Inc

(1)

Olema Pharmaceuticals

(1)

(1)

Ono Pharmaceutical Co [jp

(1)

Ontario Inst For Cancer R

(1)

(1)

Orion Biotechnology Usa C

(1)

Oryzon Genomics S A

(1)

Osanni Bio Inc [us]; Jung

(1)

Otsuka America Pharmaceut

(1)

Otsuka Pharma Co Ltd [jp]

(1)

Owp Pharmaceuticals Inc

(1)

Oxford Univ Innovation Li

(1)

PLA Air Force Medical Uni

(1)

PTC Therapeutics

(1)

Panshi Medical Biotechnol

(1)

Papyrus Therapeutics Inc

(1)

Paragon Therapeutics

(1)

(1)

Pasithea Therapeutics Cor

(1)

Peking Union Medical Coll

(1)

Peking Union Medical Coll

(1)

Peking Union Medical Coll

(1)

Peking University Third H

(1)

(1)

Petroleo Brasileiro S A P

(1)

Pharma Foods Int Co Ltd

(1)

(1)

Pharmaforceiq Inc

(1)

(1)

(1)

Phi Therapeutics Inc

(1)

Pingxiang Health Vocation

(1)

Platinum Pharma Service S

(1)

(1)

Popro Shanghai Pharma Sci

(1)

Porton Pharma Solutions

(1)

Principia Biopharma

(1)

Proteologix Us Inc

(1)

(1)

Pulike Biological Eng Inc

(1)

Pyxis Oncology Inc

(1)

Qilu Animal Health Produc

(1)

Qilu Hospital of Shandong

(1)

Qingdao Central Hospital

(1)

Qingdao Central Hospital;

(1)

Qingdao Laoshan Mineral W

(1)

Qingdao Municipal Hospita

(1)

Qingdao Orbiepharm Pharma

(1)

Qingdao Ruierweite Biotec

(1)

Qingdao University

(1)

Qingdao Wanwuxinsheng Bio

(1)

Qinghai Salt Lake Industr

(1)

Qinghai Xiadu Pharmaceuti

(1)

Qionghai Hospital Of Trad

(1)

Quanta Therapeutics

(1)

Qufu Normal University

(1)

(1)

Re Vana Therapeutics Ltd

(1)

Recursion Pharmaceuticals

(1)

Regents of the University

(1)

Relay Therapeutics

(1)

Remab Therapeutics S L

(1)

Remepy Health Ltd

(1)

Renji Hospital Shanghai J

(1)

Replicate Bioscience

(1)

Resdevco Res And Developm

(1)

Resmed Digital Medical In

(1)

Riboscience Llc

(1)

(1)

Ringpu Biotechnology Co L

(1)

Rongshan Pharmaceutical C

(1)

Ruenhuei Biopharmaceutica

(1)

Ruijin Hospital Shanghai

(1)

Ryvu Therapeutics

(1)

S Alpha Therapeutics Inc

(1)

(1)

Sage Therapeutics

(1)

Sagetech Medical Equipmen

(1)

Sainuojin Pharmaceutical

(1)

Salubris Chengdu Biotech

(1)

Sanofi Biotechnology [fr]

(1)

Sanofi Sa [fr]; UCB Bioph

(1)

Sanya Central Hospital Ha

(1)

ScinnoHub Pharmaceutical

(1)

Scribe Therapeutics

(1)

(1)

Second Hospital of Hebei

(1)

Sensorium Therapeutics

(1)

Seoul National University

(1)

Shaanxi Jinzheng Pharmace

(1)

Shaanxi Traditional Chine

(1)

Shaanxi University of Sci

(1)

Shaanxi Xiyue Pharmaceuti

(1)

Shaanxi Yuanzhi Pharmaceu

(1)

Shah Hiral [in]; Shah Gau

(1)

Shandong Anaiysis And Tes

(1)

Shandong Anshun Pharmaceu

(1)

Shandong Bestcomm Pharmac

(1)

Shandong Boan Biotechnolo

(1)

Shandong Borui Pharmaceut

(1)

Shandong Fanhui Biologica

(1)

Shandong Fine Chemical Te

(1)

Shandong Guobang Pharmace

(1)

Shandong Guojiutang Pharm

(1)

Shandong Huanong Biologic

(1)

Shandong Jinan The Third

(1)

Shandong Longchang Animal

(1)

Shandong Lukang Shelile P

(1)

Shandong New Time Pharmac

(1)

Shandong New Time Pharmac

(1)

Shandong New Time Pharmac

(1)

Shandong Nhu Pharmaceutic

(1)

Shandong Simcere Biopharm

(1)

Shandong Sirui Pharmaceut

(1)

Shandong University

(1)

Shandong Xinhua Pharmaceu

(1)

Shandong Xinyi Pharmaceut

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Argo Biopharmace

(1)

Shanghai Bowang Pharmaceu

(1)

Shanghai Cell Therapy Gro

(1)

Shanghai Celliver Biotech

(1)

Shanghai City Jingan Dist

(1)

Shanghai Data Group Co Lt

(1)

Shanghai Donghai Vocation

(1)

Shanghai EpimAb Biotherap

(1)

Shanghai Fosun Pharmaceut

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hospital Traditi

(1)

Shanghai Huao Co Ltd

(1)

Shanghai Huaota Biopharma

(1)

Shanghai Huazhiwo Biomedi

(1)

Shanghai Huilun Pharmaceu

(1)

Shanghai Inst Of Pharmace

(1)

Shanghai Institute Of Mea

(1)

Shanghai Institute of Mat

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jinfukang Pharma

(1)

Shanghai Jingan Pengpu Co

(1)

Shanghai Jingquan Investm

(1)

Shanghai Jingxin Biologic

(1)

Shanghai Jziy Biotechnolo

(1)

Shanghai Maiji Pharmaceut

(1)

Shanghai Meiyue Biotech D

(1)

Shanghai MicuRx Pharmaceu

(1)

Shanghai Mixi Network Tec

(1)

Shanghai No 4 People\'s H

(1)

Shanghai Pharmaceutical S

(1)

Shanghai Pharmaceuticals

(1)

Shanghai Puteshun Health

(1)

Shanghai Qilu Pharmaceuti

(1)

Shanghai Ruotuo Bioscienc

(1)

Shanghai University

(1)

Shanghai University of Tr

(1)

Shanghai Yidi Biotechnolo

(1)

Shangqiu Xianghe Pharmace

(1)

Shangrao Aier Eye Hospita

(1)

Shantou Mebo Pharmaceutic

(1)

Shantou Rongcheng Electri

(1)

Shanxi Jinbo Bio Pharmace

(1)

Shanxi Medical University

(1)

Shanxi University of Chin

(1)

Shanxi Xinyu Pharmaceutic

(1)

Shanxi Zhendong Pharmaceu

(1)

Shenyang Xindi Pharmaceut

(1)

Shenzhen Antmed

(1)

Shenzhen Bao\'an Traditio

(1)

Shenzhen China Resources

(1)

Shenzhen Finder Biotech C

(1)

Shenzhen Hepalink Pharmac

(1)

Shenzhen Jiebo Biotechnol

(1)

Shenzhen NuboMed Technolo

(1)

Shenzhen Qianzhikang Chin

(1)

Shenzhen Ruihua Pharmaceu

(1)

Shenzhen Tegede Medical T

(1)

Shenzhen University; The

(1)

Shenzhen University; Zhej

(1)

Shenzhen Wanhe Pharmaceut

(1)

Shenzhen Weiguang Biologi

(1)

Shenzhen Xiuli Pharmaceut

(1)

Shenzhen Yueqian Creative

(1)

Shihezi University

(1)

Shijiazhuang Huaxu Pharma

(1)

Shijiazhuang Xinfuda Phar

(1)

Shineway Pharmaceutical G

(1)

Shiyan Mulong Biological

(1)

Shujing Biopharma Co Ltd

(1)

Sichuan Academy of Chines

(1)

Sichuan Guorui Pharmaceut

(1)

Country

X

China Patent News

WIPO Patent News

Taiwan Patent News

European Patent News

Philippines Patent News

Norway Patent News

Status

X

1 - 100 of 1609 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

State Intellectual Property Office of China Receives Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Tibet Cheezheng Tibetan Medicine Co Ltd Pate..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has received Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Tibet Cheezheng Tibetan Medicine Co Ltd patent application for Corydalis Pygmaea Terminal Bud Organogenesis and In-vitro Rapid Propagation Method. Zhang Chengcai, Guo Lanp..

Taiwan Patent Office Receives Neomorph Inc Patent Application for Substituted (piperidin-4-yl)-1,5-naphthyridine and (piperidin-4-yl)quinoline Derivatives and Uses Thereof

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Taiwan Patent Office has received Neomorph Inc patent application for Substituted (piperidin-4-yl)-1,5-naphthyridine and (piperidin-4-yl)quinoline Derivatives and Uses Thereof. Griffin Jennifer Rae, Liu Xiaoxi and Tellew John developed the invention. The patent application number is TW20240142176 20241104. T..

State Intellectual Property Office of China Receives Jiangsu Jingsen Biological Medicine New Material Tech Co Ltd Patent Application for New Application of Composition

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has received Jiangsu Jingsen Biological Medicine New Material Tech Co Ltd patent application for New Application of Composition. Ma Yong, Lu Jingbo, Yang Lipin, Xu Chunlin and Jiang Chenyang developed the invention. The patent application number is CN20251245342 2..

U.S. Patent and Trademark Office Receives Nyrada Pty Ltd Patent Application for Compounds for Treatment of Excitotoxicity

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has received Nyrada Pty Ltd patent application for Compounds for Treatment of Excitotoxicity. Coghlan Phillip, Evison Benny and Parmar Jasneet developed the invention. The patent application number is US202619460795 20260127. The patent publication number is US20260152495..

Nuclidium AG and University of Basel Apply for Patent on Somatostatin Receptor-targeting Radiopharmaceuticals and Uses Thereof

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Nuclidium AG and University of Basel have applied United States patent for Somatostatin Receptor-targeting Radiopharmaceuticals and Uses Thereof. Jaafar-thiel Leila, De Rose Francesco and Fani Melpomeni developed it. The patent application number is US202519375103 20251030. The patent publication number ..

U.S. Patent and Trademark Office Releases Turnstone Biologics Corp Patent Application for Compositions and Methods for Generating Neo-antigen Reactive Tumor Infiltrating Lymphocyte..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has released Turnstone Biologics Corp patent application for Compositions and Methods for Generating Neo-antigen Reactive Tumor Infiltrating Lymphocytes. This invention was developed by Nikota James Kenneth, Pikor Larissa A, Twumasi-boateng Kwame, Stojdl David F and Langer T..

Golden Health Guangdong Biotechnology Co Ltd Submits United States Patent Application for Method and Kit for Treating Microsatellite-stable Solid Tumors

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Golden Health Guangdong Biotechnology Co Ltd has submitted a patent application for Method and Kit for Treating Microsatellite-stable Solid Tumors. This invention was developed by Zhou Jinlin, Lin Liwei, Hu Yanfeng, Lu Yujing, Zhou Zhishan, Yang Xiang, Huang Baohua and Li Huiling. The patent application ..

Altin Biosciences Corp Submits United States Patent Application for Crila and EGCG Compositions for Treatment of Fibroids

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Altin Biosciences Corp has submitted a patent application for Crila and EGCG Compositions for Treatment of Fibroids. This invention was developed by Mckinney Charlotte Sue and Payne Adam Joshua. The patent application number is US202519411873 20251208. The patent publication number is US20260151448 (A1)...

Emergent Biodefense Operations Lansing LLC Submits United States Patent Application for Formulations of Brincidofovir

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Emergent Biodefense Operations Lansing LLC has submitted a patent application for Formulations of Brincidofovir. This invention was developed by Kabir Mohammed, Naderer Odin Johann and Grossi Irma Marisa. The patent application number is US202519379308 20251104. The patent publication number is US2026015..

MBP Co Ltd Submits Patent Application for Composition for Preventing or Treating Periodontitis Comprising Cannabidiol and Taurine

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- MBP Co Ltd has submitted a patent application for Composition for Preventing or Treating Periodontitis Comprising Cannabidiol and Taurine. Soh Yun-jo, Shim Hyun-joo and Im Chang-jin developed the invention. The patent application number is US202319123582 20230804. The patent publication number is US20260..

U.S. Patent and Trademark Office Publishes Oryzon Genomics SA Patent Application for Combinations of LSD1 Inhibitors and Menin Inhibitors for Treating Cancer

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has published Oryzon Genomics SA patent application for Combinations of LSD1 Inhibitors and Menin Inhibitors for Treating Cancer. The invention was developed by Sacilotto Natalia and Soliva Soliva Robert. The patent application number is US202319131407 20231124. The paten..

Eisbach Bio GmbH Applies for Patent on Inhibitors of Viral Helicases Binding to a Novel Allosteric Binding Site

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Eisbach Bio GmbH has applied United States patent for Inhibitors of Viral Helicases Binding to a Novel Allosteric Binding Site. Menzer William M, Knobloch Gunnar, Schomburg Adrian, Lieleg Corinna and Sennhenn Peter developed it. The patent application number is US202218703992 20221028. The patent publica..

Veradermics Incorporated Submits United States Patent Application for Compositions and Methods of Use for Modified Release Minoxidil

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Veradermics Incorporated has submitted a patent application for Compositions and Methods of Use for Modified Release Minoxidil. This invention was developed by Waldman Reid. The patent application number is US202519427955 20251219. The patent publication number is US20260151393 (A1). International Patent..

Xi'an Shisong Tech Co Ltd Seeks Patent for Cinnamobactin and Use Thereof in Treatment of Bacterial Infection

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Xi'an Shisong Tech Co Ltd has sought patent for Cinnamobactin and Use Thereof in Treatment of Bacterial Infection. This invention was developed by Liu Bing. The patent application number is US202519408096 20251203. The patent publication number is US20260151374 (A1). International Patent Classification c..

Hallux Inc Files United States Patent Application for Compositions and Methods of Treatment of Onychomycosis and Onycholysis

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Hallux Inc has filed a patent application for Compositions and Methods of Treatment of Onychomycosis and Onycholysis. This invention was developed by Orr Robert L, Agee Christopher Ronald and Cauwenbergh Geert. The patent application number is US202619457055 20260122. The patent publication number is US2..

State Intellectual Property Office of China Releases Guangxi Wuzhou Pharm Group Co Patent Application for Specific Chromatogram Establishment Method of Green Tangerine Peel in Live..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has released Guangxi Wuzhou Pharm Group Co patent application for Specific Chromatogram Establishment Method of Green Tangerine Peel in Liver-removing Decoction. This invention was developed by Liang Yongmei, Cen Jinni, Yang Meimei, Lu Yuanheng and Zhang Zhaojia. ..

Nanjing Zhongshan Pharm Co Ltd Applies for Patent on Method for Determining Content of Volatile Component Geranione in Kernel-bighead Atractylodes Rhizome Stomach-invigorating Gran..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Nanjing Zhongshan Pharm Co Ltd has applied Chinese patent for Method for Determining Content of Volatile Component Geranione in Kernel-bighead Atractylodes Rhizome Stomach-invigorating Granules. Wang Haili, Zhao Kaijun, Zhang Qing and Guo Jian developed it. The patent application number is CN20251221306 202..

The University of Hong Kong and Centre For Virology Vaccinology and Therapeutics Ltd Submit United States Patent Application for Human Tryptophanyl-trna Synthetase Transgenic Mouse..

Pharmaceutical

| Tue 09 Jun 2026

Alexandria, June 9 -- The University of Hong Kong and Centre For Virology Vaccinology and Therapeutics Ltd have submitted a patent application for Human Tryptophanyl-trna Synthetase Transgenic Mouse Models. This invention was developed by Teng Lee Lee, Li Sze Ming Kenneth, Yeung Man Lung and Jia Lilong. The patent application..

Shanghai Jiao Tong University and Shanghai Aifa Investment Man Co Ltd File Chinese Patent Application for Method for Identifying Rice Grain Filling Stage Process Based on Starch Pa..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Shanghai Jiao Tong University and Shanghai Aifa Investment Man Co Ltd have filed a patent application for Method for Identifying Rice Grain Filling Stage Process Based on Starch Particle Surface Lipid. This invention was developed by Sui Zhongquan, Zhang Xinyu, Nan Liu, Ma Mengting, Li Lei and Li Shuangqing. ..

Shanghai Jiao Tong University and Shanghai Highway Bridge Group File Chinese Patent Application for Rotary Grouting Lease Reduction Test Device

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Shanghai Jiao Tong University and Shanghai Highway Bridge Group have filed a patent application for Rotary Grouting Lease Reduction Test Device. This invention was developed by Li Mingguang, Wang Jianfeng, Zhen Liang, Chen Jinjian, Zhang Tao, Fang Tao and Chen Feng. The patent application number is CN202511..

Shanghai Institute of Pharmaceutical Industry Co Ltd and China State Institute of Pharmaceutical Industry Co Ltd Submit Chinese Patent Application for Uricase Mutant and Applicatio..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Shanghai Institute of Pharmaceutical Industry Co Ltd and China State Institute of Pharmaceutical Industry Co Ltd have submitted a patent application for Uricase Mutant and Application Thereof. This invention was developed by Tang Xiaoyuan and Hu Haifeng. The patent application number is CN202511751861 20251..

Kanglong Huacheng Ningbo Tech Development Co Ltd and Pharmaron Beijing New Drug Tech Co Ltd Submit Chinese Patent Application for Imine Reductase Mutant as Well as Preparation Meth..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Kanglong Huacheng Ningbo Tech Development Co Ltd and Pharmaron Beijing New Drug Tech Co Ltd have submitted a patent application for Imine Reductase Mutant as Well as Preparation Method and Application Thereof. This invention was developed by Tong Yapei, Ma Sitan and Luo Guangxiang. The patent application nu..

Shanghai Data Group Co Ltd and Shanghai Jiao Tong University Apply for Patent on Data Security Classification and Grading System and Method Based on Large Language Model

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Shanghai Data Group Co Ltd and Shanghai Jiao Tong University have applied Chinese patent for Data Security Classification and Grading System and Method Based on Large Language Model. Li Xiaoshan, Zhou Qiang, Li Yunshen, Zhao Hai and Yang Dongjie developed it. The patent application number is CN202511696427 ..

Jiangsu Hengrui Pharmaceuticals Co Ltd and Shanghai Hengrui Pharmaceutical File Taiwan Patent Application for a Pharmaceutical Composition Comprising Bispecific Antibody Specifical..

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Jiangsu Hengrui Pharmaceuticals Co Ltd and Shanghai Hengrui Pharmaceutical have filed a patent application for a Pharmaceutical Composition Comprising Bispecific Antibody Specifically Binds to GPRC5D and CD3. This invention was developed by Shan Shuang and Tian Chen-min. The patent application number is TW20..

Sanofi SA and UCB Biopharma Submit Taiwan Patent Application for Synthetic Method

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Sanofi SA and UCB Biopharma have submitted a patent application for Synthetic Method. This invention was developed by Barthes Matthieu, Baylon Christophe, Greciet Helene, Cerfontaine Patrick, Gerard Julien and Petit Sylvain. The patent application number is TW20240137121 20240927. The patent publication numb..

Neurimmune AG and Alexion Pharmaceuticals File Taiwan Patent Application for Anti-transthyretin Antibody, Compositions Comprising Said Antibody and Methods for Treating or Preventi..

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Neurimmune AG and Alexion Pharmaceuticals have filed a patent application for Anti-transthyretin Antibody, Compositions Comprising Said Antibody and Methods for Treating or Preventing Transthyretin-mediated Amyloidosis. This invention was developed by Michalon Aubin, Salzmann Michael, Godawat Rahul and Sui Sigu..

Ono Pharmaceutical Co and University Sapporo Medical Submit Patent Application for HLA/tumor Antigen PVT1 Derived Peptide Complex Specific Antibody

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Ono Pharmaceutical Co and University Sapporo Medical have submitted a patent application for HLA/tumor Antigen PVT1 Derived Peptide Complex Specific Antibody. Tsukahara Tomohide, Torigoe Toshihiko, Oyagi Atsushi and Maeda Tatsuo developed the invention. The patent application number is TW20240132810 20240830..

Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Hansoh Biomedical Co Ltd and Hansoh Bio LLC Submit Taiwan Patent Application for Polycyclic Compound, Preparation Methods and M..

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Hansoh Biomedical Co Ltd and Hansoh Bio LLC have submitted a patent application for Polycyclic Compound, Preparation Methods and Medicinal Uses Thereof. This invention was developed by Khanna Avinash and Lee Chin-hung. The patent application number is TW2..

Shanghai Jiao Tong University and Alipay Hangzhou Digital Service Tech Co Ltd Submit Chinese Patent Application for General Time Sequence Prediction Method and Electronic Equipment

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Shanghai Jiao Tong University and Alipay Hangzhou Digital Service Tech Co Ltd have submitted a patent application for General Time Sequence Prediction Method and Electronic Equipment. This invention was developed by Wei Xiuyuan, Gao Xiaofeng, Ma Lintao, Fang Yuchen and Sun Yinbo. The patent application numb..

Jiangxi Changshuo Outdoor Leisure Products Co Ltd, Shenzhen Changshuo New Textile Mat Co Ltd and Tianjin University of Science and Technology Submit United States Patent Applicatio..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Jiangxi Changshuo Outdoor Leisure Products Co Ltd, Shenzhen Changshuo New Textile Mat Co Ltd and Tianjin University of Science and Technology have submitted a patent application for Fabric-based Breathable and Washable Wearable Sensor and Manufacturing Method Therefor. This invention was developed by Liu Ya..

The Broad Institute Inc and Massachusetts Institute Of Technology Apply for Patent on Delivery, Use and Therapeutic Applications of the CRISPR-Cas Systems and Compositions for Targ..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- The Broad Institute Inc and Massachusetts Institute Of Technology have applied United States patent for Delivery, Use and Therapeutic Applications of the CRISPR-Cas Systems and Compositions for Targeting Disorders and Diseases Using Particle Delivery Components. Dahlman James, Platt Randall Jeffrey, Anderso..

Centro Di Riferimento Oncologico Di Aviano and University Degli Studi Di Trieste Submit Patent Application for Anti-GPC1 Monoclonal Antibody, Therapeutic and Diagnostic Uses Thereo..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Centro Di Riferimento Oncologico Di Aviano and University Degli Studi Di Trieste have submitted a patent application for Anti-GPC1 Monoclonal Antibody, Therapeutic and Diagnostic Uses Thereof. Toffoli Giuseppe, Dal Bo Michele, Macor Paolo, Busato Davide, Capolla Sara and Di Cintio Federica developed the inv..

Nat University Corporation Okayama University and Foot Silver Co Ltd Submit Chinese Patent Application for Formulations for Cancer Treatment and Pharmaceutical Compositions Compris..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Nat University Corporation Okayama University and Foot Silver Co Ltd have submitted a patent application for Formulations for Cancer Treatment and Pharmaceutical Compositions Comprising Same. This invention was developed by Matsuura Eiji, Ohki Takashi and Ishimoto Manabu. The patent application number is CN..

Youwe Zhuhai Biotechnology Co Ltd and Creway Zhuhai Pharmaceutical Tech Co Ltd Submit United States Patent Application for Microneedle Patch, Microneedle Mold and Preparation Metho..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Youwe Zhuhai Biotechnology Co Ltd and Creway Zhuhai Pharmaceutical Tech Co Ltd have submitted a patent application for Microneedle Patch, Microneedle Mold and Preparation Method for Microneedle Patch. This invention was developed by Leng Gang, Li Chengguo, Ma Yonghao, Chen Jinyong, Chen Lianhua and Li Yanfe..

Abtis Co Ltd and Research & Business Foundation Sungkyunkwan University Submit United States Patent Application for Antibody-drug Conjugate Comprising Anti-claudin-18.2 Antibody, a..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Abtis Co Ltd and Research & Business Foundation Sungkyunkwan University have submitted a patent application for Antibody-drug Conjugate Comprising Anti-claudin-18.2 Antibody, and Therapeutic Use Thereof for Cancer. This invention was developed by Chung Sang Jeon, Oh Yeong Soo, Kim Juhwan, Lee Younggeun, Seo..

Henan Agricultural University, Henan Hemu Animal Pharmaceutical Co Ltd and Yongcheng Livestock Dev Service Center Apply for Patent on Long-acting Tick-repelling and Killing Compoun..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Henan Agricultural University, Henan Hemu Animal Pharmaceutical Co Ltd and Yongcheng Livestock Dev Service Center have applied United States patent for Long-acting Tick-repelling and Killing Compounded Plant Essential Oil Nano-emulsion and Preparation Method Thereof. Jian Fuchun, Li Senyang, Liu Yifei, Jian..

Guangzhou Magpie Pharmaceuticals Co L T D and Guangzhou Magpie Pharmaceuticals Co Ltd Submit United States Patent Application for Use of Tetramethylpyrazine Nitrone Derivatives in ..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Guangzhou Magpie Pharmaceuticals Co L T D and Guangzhou Magpie Pharmaceuticals Co Ltd have submitted a patent application for Use of Tetramethylpyrazine Nitrone Derivatives in the Treatment of Ischemic Stroke. This invention was developed by Wang Yuqiang, Liu Wei and Gu Jianbo. The patent application num..

Shanghai Hansoh Biomedical Co Ltd and Jiangsu Hansoh Pharmaceutical Group Submit Patent Application for Salt and Crystal Form of Heterocyclic Derivative Inhibitor, and Preparation ..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Shanghai Hansoh Biomedical Co Ltd and Jiangsu Hansoh Pharmaceutical Group have submitted a patent application for Salt and Crystal Form of Heterocyclic Derivative Inhibitor, and Preparation Method Therefor and Use Thereof. Zhan Xiaolan, Li Yuanyuan and Guo Linsong developed the invention. The patent appl..

Biper Therapeutics SAS, Inserm Institut National De La Sante Et De La Rech Medicale, University Cote Dazur and Centre National De La Recherche Scient CNRS Seek Patent for Compositi..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Biper Therapeutics SAS, Inserm Institut National De La Sante Et De La Rech Medicale, University Cote Dazur and Centre National De La Recherche Scient CNRS have sought patent for Compositions Comprising a Benzene Sulfonamide Thiazole Compound. This invention was developed by Ronco Cyril, Benhida Rachid, Rocc..

State Intellectual Property Office of China Releases Keli Italia Co Ltd Patent Application for Probiotics as Vaccine Immunologic Adjuvants

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has released Keli Italia Co Ltd patent application for Probiotics as Vaccine Immunologic Adjuvants. This invention was developed by Elie Marina and Lim Jong-yoon. The patent application number is CN20248019075 20240314. The patent publication number is CN121548430..

Panshi Medical Biotechnology Co Ltd Submits Chinese Patent Application for Methods and Compositions for Vaccines Targeting Dendritic Cells

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Panshi Medical Biotechnology Co Ltd has submitted a patent application for Methods and Compositions for Vaccines Targeting Dendritic Cells. This invention was developed by Weng Qihui, Li Zhengxin, Fan Chenyou, Wang Shiwen and Wu Junyi. The patent application number is CN20248022302 20240408. The patent publ..

Immunwork Inc Submits Chinese Patent Application for Pharmaceutical Formulation of Glucagon-like Peptide-1 Receptor Agonist Peptides Suitable for Sublingual Administration

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Immunwork Inc has submitted a patent application for Pharmaceutical Formulation of Glucagon-like Peptide-1 Receptor Agonist Peptides Suitable for Sublingual Administration. This invention was developed by Zhang Ziwen, Chen Jianren and Zhu Xinmao. The patent application number is CN20258003795 20250117. The ..

Contex Biosciences USA Inc Submits Chinese Patent Application for Bicyclic Heteroaryl Compounds

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Contex Biosciences USA Inc has submitted a patent application for Bicyclic Heteroaryl Compounds. This invention was developed by Huang Xianhai, Tang Haifeng, Simon Anja, Yang Dexi, Sun Yaxiong, Roitman Vladimir and Duan Jingwu. The patent application number is CN20248048504 20240522. The patent publication ..

Concaro Therapeutics Inc Applies for Patent on Small Molecule Inhibitors of P27

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Concaro Therapeutics Inc has applied Chinese patent for Small Molecule Inhibitors of P27. Devita Robert J and Chen Guan-yi developed it. The patent application number is CN20248042388 20240515. The patent publication number is CN121548417 (A). International Patent Classification codes are A61K31/18, A61K31/..

Vision Therapeutics Inc Submits Patent Application for Synthesis of 2-(carbamoyloxy)-n, N, N-trimethylethyl-1-ammonium Salt

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Vision Therapeutics Inc has submitted a patent application for Synthesis of 2-(carbamoyloxy)-n, N, N-trimethylethyl-1-ammonium Salt. Grinstead Troy, Reid John G and Tesser Henricus Leonardus Adrianus developed the invention. The patent application number is CN20248047460 20240614. The patent publication num..

Hyrolix Dev AG Files Chinese Patent Application for Freeze-dried Metolazone Formulations for Non-digestive Administration

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Hyrolix Dev AG has filed a patent application for Freeze-dried Metolazone Formulations for Non-digestive Administration. This invention was developed by Patil Abhishek. The patent application number is CN20248048372 20240724. The patent publication number is CN121548408 (A). International Patent Classificat..

State Intellectual Property Office of China Publishes Comanche Biopharma Inc Patent Application for Nucleic Acid Compound Formulations and Uses Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Comanche Biopharma Inc patent application for Nucleic Acid Compound Formulations and Uses Thereof. The invention was developed by Farr Allan Robert, Mottram Robert and Mompala Jorge. The patent application number is CN20248045950 20240711. The patent..

State Intellectual Property Office of China Publishes Gansu Institute for Drug Control Patent Application for Method for Identifying Species of Fructus Viticis and Application

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Gansu Institute for Drug Control patent application for Method for Identifying Species of Fructus Viticis and Application. The invention was developed by Zhang Shengjie, Ma Xiao, Li Donghua, Zhang Mingtong, Zhu Yajun, Guo Xiaoxia, Li Xin, Han Xiaoxiao, ..

U.S. Patent and Trademark Office Releases Sichuan Second Hospital Of TCM and Sichuan Acad Of Chinese Medicine Sciences Patent Application for Method for Simultaneous Determination ..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has released Sichuan Second Hospital Of TCM and Sichuan Acad Of Chinese Medicine Sciences patent application for Method for Simultaneous Determination of Chlorogenic Acid, Ferulic Acid, Dracohodin, Cinnamaldehyde, Ligustilide, and Osthole in Xiangdu Huoxue Plaster. This inve..

State Intellectual Property Office of China Releases Yingxi Intelligent Tech Intellectual Property Co Ltd Patent Application for Crystalline Beta-lactam Derivative and Use Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has released Yingxi Intelligent Tech Intellectual Property Co Ltd patent application for Crystalline Beta-lactam Derivative and Use Thereof. This invention was developed by Yin Yushu and Liang Xing. The patent application number is CN20248048211 20240719. The pate..

State Intellectual Property Office of China Publishes Suzhou Pairui Biotechnology Co Ltd Patent Application for Indole Compound as Well as Preparation Method and Application Thereo..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Suzhou Pairui Biotechnology Co Ltd patent application for Indole Compound as Well as Preparation Method and Application Thereof. The invention was developed by Wang Jingfang, Peng Cheng, Song Zhidong, Wang Ying and Tong Siyu. The patent application n..

Integrative Res Laboratories Sweden AB Seeks Patent for Pharmaceutically Acceptable Salts of 3-(2, 3-difluorophenoxy) Azetidine and Uses Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 9 -- Integrative Res Laboratories Sweden AB has sought patent for Pharmaceutically Acceptable Salts of 3-(2, 3-difluorophenoxy) Azetidine and Uses Thereof. This invention was developed by Kazachonowka Galina, Ecava Bruno, Fernandez Ana, Buksa Maija, Nguyen Lien and Watters Nicholas. The patent application number..

U.S. Patent and Trademark Office Receives Jinis Co Ltd Patent Application for Thrombolytic Agents for Intravascular Clots

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has received Jinis Co Ltd patent application for Thrombolytic Agents for Intravascular Clots. Hong Seong Tshool, Kim Hyeon Jin and Hassan Mdmehedi developed the invention. The patent application number is US202619461724 20260128. The patent publication number is US2026015..

U.S. Patent and Trademark Office Publishes Eleos Pharmaceuticals Inc Patent Application for Topical Composition for Improved Healing of Open Wounds

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has published Eleos Pharmaceuticals Inc patent application for Topical Composition for Improved Healing of Open Wounds. The invention was developed by Buice Mona E, Sailors David M and Greeson Joshua Z. The patent application number is US202519258146 20250702. The patent ..

U.S. Patent and Trademark Office Publishes C/o Animal Microbiome Analytics Inc Patent Application for Products and Methods for Therapeutic Administration of Microorganisms to Non-h..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has published C/o Animal Microbiome Analytics Inc patent application for Products and Methods for Therapeutic Administration of Microorganisms to Non-human Animals. The invention was developed by Ganz Holly H, Goodman Kari R and Martin Alexandra. The patent application nu..

Shenzhen Wanhe Pharmaceutical Co Ltd Files United States Patent Application for Method for Drying Fecal Microbiota Multilayer Dripping Pills

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Shenzhen Wanhe Pharmaceutical Co Ltd has filed a patent application for Method for Drying Fecal Microbiota Multilayer Dripping Pills. This invention was developed by Wang Zhongsun, Jin Yang, Ke Baisheng, Huang Weijia and Ma Jun. The patent application number is US202619460874 20260127. The patent publica..

Sightstream Biotherapeutics Inc Seeks Patent for Compositions for the Treatment of Disease

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Sightstream Biotherapeutics Inc has sought patent for Compositions for the Treatment of Disease. This invention was developed by Jasek Mark Christopher, Whitlock Norris Andrew, Zhao Jiagang and Skerlj Renato. The patent application number is US202319100395 20230802. The patent publication number is US202..

U.S. Patent and Trademark Office Receives Aronora Inc, Oregon Health & Science University and Ionis Pharmaceuticals Patent Application for Methods for Safely Reducing Thrombopoieti..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has received Aronora Inc, Oregon Health & Science University and Ionis Pharmaceuticals patent application for Methods for Safely Reducing Thrombopoietin. Gruber Andras, Tucker Erik, Monia Brett P and Revenko Alexey developed the invention. The patent application number is..

Cardiol Therapeutics Inc Submits Patent Application for Cannabidiol Compositions for Use in Treating Heart Conditions

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Cardiol Therapeutics Inc has submitted a patent application for Cannabidiol Compositions for Use in Treating Heart Conditions. Smith Eldon Raymond, Ristevski Blagoja and Bolton Anthony Ernest developed the invention. The patent application number is US202619460082 20260126. The patent publication number ..

U.S. Patent and Trademark Office Publishes Nexzol Pharma Inc Patent Application for Transdermal Formulation for the Treatment of Pain and/or Inflammation

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has published Nexzol Pharma Inc patent application for Transdermal Formulation for the Treatment of Pain and/or Inflammation. The invention was developed by Fracassi Joseph M and Scarlata Thomas J. The patent application number is US202519269927 20250715. The patent publi..

U.S. Patent and Trademark Office Receives Aconcagua Bio Inc Patent Application for Compounds, Compositions, and Methods

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has received Aconcagua Bio Inc patent application for Compounds, Compositions, and Methods. De Graaf Chris, Gao Zhenting, Guo Xin, Lei Hui, Li Cui, Lu Chunliang, Xue Ding, Zhang Haizhen and Zhang Zhuming developed the invention. The patent application number is US20261945..

Syndax Pharmaceuticals Inc Submits United States Patent Application for Combinations of Menin Inhibitors and Cyp3a4 Inhibitors and Methods of Use Thereof

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Syndax Pharmaceuticals Inc has submitted a patent application for Combinations of Menin Inhibitors and Cyp3a4 Inhibitors and Methods of Use Thereof. This invention was developed by Mcgeehan Gerard M, Ordentlich Peter, Rosen Galit and Smith Steven A. The patent application number is US202619458303 2026012..

Tanabe Pharma Corp Seeks Patent for Pharmaceutical Composition for Hailey-hailey Disease and Use Thereof

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Tanabe Pharma Corp has sought patent for Pharmaceutical Composition for Hailey-hailey Disease and Use Thereof. This invention was developed by Saito Ryuta. The patent application number is US202519323465 20250909. The patent publication number is US20260151388 (A1). International Patent Classification co..

Teh Seng Pharmaceutical Mfg Co Ltd Applies for Patent on Transdermal Patch

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Teh Seng Pharmaceutical Mfg Co Ltd has applied United States patent for Transdermal Patch. Hsu Shih-pin developed it. The patent application number is US202519057136 20250219. The patent publication number is US20260151381 (A1). International Patent Classification codes are A61K31/465 and A61K9/70. Coope..

U.S. Patent and Trademark Office Publishes Institut National De La Sante Et De La Rech Medicale, University Cote Dazur, Biper Therapeutics and Centre National De La Recherche Scien..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has published Institut National De La Sante Et De La Rech Medicale, University Cote Dazur, Biper Therapeutics and Centre National De La Recherche Scientifique patent application for Combination Therapy for the Treatment of Cancer. The invention was developed by Ronco Cyril, ..

Nacuity Pharmaceuticals Inc Files United States Patent Application for Method for Preparation of N-acetyl Cysteine Amide or Di- N-acetyl Cysteine Amide and Derivatives

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Nacuity Pharmaceuticals Inc has filed a patent application for Method for Preparation of N-acetyl Cysteine Amide or Di- N-acetyl Cysteine Amide and Derivatives. This invention was developed by Wall G Michael. The patent application number is US202619465413 20260130. The patent publication number is US202..

Shanghai Jziy Biotechnology Co Ltd Submits United States Patent Application for a Pharmaceutical Composition for Effectively Preventing Deactivation and Enhancing the Targeting Act..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Shanghai Jziy Biotechnology Co Ltd has submitted a patent application for a Pharmaceutical Composition for Effectively Preventing Deactivation and Enhancing the Targeting Activity of SN Triple-bond Compounds, and a Method for Preparing the Same. This invention was developed by Hao Wei, Hao Yangfan and Qiao ..

DXM Pharmaceutical Inc Applies for Patent on Concentrated Aqueous Diphenhydramine Hcl Formulations

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- DXM Pharmaceutical Inc has applied United States patent for Concentrated Aqueous Diphenhydramine Hcl Formulations. Thuesen Mark Lawrence, Sanders Steve Shane and Bannister Steve J developed it. The patent application number is US202519376631 20251031. The patent publication number is US20260151359 (A1). ..

Astrocyte Pharmaceuticals Inc Applies for Patent on Fast-dissolving Dosage Forms and Uses Thereof

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Astrocyte Pharmaceuticals Inc has applied United States patent for Fast-dissolving Dosage Forms and Uses Thereof. Poe Russell Birch and Grother Leon Paul developed it. The patent application number is US202319126330 20231103. The patent publication number is US20260151345 (A1). International Patent Class..

U.S. Patent and Trademark Office Receives Transp Authority Inc Patent Application for Layered Edible Product for Multi-stage Dosing of Multi-function Active Pharmaceutical Ingredie..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- U.S. Patent and Trademark Office has received Transp Authority Inc patent application for Layered Edible Product for Multi-stage Dosing of Multi-function Active Pharmaceutical Ingredients. Smith Walter Lee and Warren William developed the invention. The patent application number is US202619460817 2026012..

Thorne Intellectual Property Holdings LLC Applies for Patent on Maintaining Medicine Quality in Medicine Preparation

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Thorne Intellectual Property Holdings LLC has applied United States patent for Maintaining Medicine Quality in Medicine Preparation. Thorne Jr Gale Harrison, Thorne Gale Harrison and Thorne Kendall Patterick developed it. The patent application number is US202518831813 20250915. The patent publication nu..

S Alpha Therapeutics Inc Submits United States Patent Application for Antiviral Digital Device

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- S Alpha Therapeutics Inc has submitted a patent application for Antiviral Digital Device. This invention was developed by Choi Seung Eun, Lee Yong Sun and Hahm Ja Rang. The patent application number is US202218704652 20221027. The patent publication number is US20260151629 (A1). International Patent Clas..

Tickerworks Inc Submits Patent Application for Applicator and System for Administering and Dispensing Flowable Pharmaceutical Preparations

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Tickerworks Inc has submitted a patent application for Applicator and System for Administering and Dispensing Flowable Pharmaceutical Preparations. Perez Ramiro M developed the invention. The patent application number is US202619460138 20260126. The patent publication number is US20260151604 (A1). Intern..

Forcast Orthopedics Inc Applies for Patent on Method System and Apparatus for Drug Delivery and Treatment

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Forcast Orthopedics Inc has applied United States patent for Method System and Apparatus for Drug Delivery and Treatment. Noymer Peter D, Guzman Miguel and Quintana Reynaldo J developed it. The patent application number is US202619457387 20260123. The patent publication number is US20260151553 (A1). Inte..

Node Pharma As Submits United States Patent Application for Radiopharmaceutical Mofs for Medical Imaging

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Node Pharma As has submitted a patent application for Radiopharmaceutical Mofs for Medical Imaging. This invention was developed by Øien-ødegaard Sigurd, Mjåland Erik and Stav-noraas Tor Espen. The patent application number is US202319122924 20231101. The patent publication number is US20260151522 (A1..

Amytrx Therapeutics Inc Applies for Patent on Leukocyte-specific Cell Penetrating Molecules

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Amytrx Therapeutics Inc has applied United States patent for Leukocyte-specific Cell Penetrating Molecules. Alvarez Vernon and Gonda Matthew A developed it. The patent application number is US202218685838 20220823. The patent publication number is US20260151518 (A1). International Patent Classification c..

Thetis Pharmaceuticals LLC Files United States Patent Application for Cyclodextrin Complexes of Specialized Proresolving Mediators

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Thetis Pharmaceuticals LLC has filed a patent application for Cyclodextrin Complexes of Specialized Proresolving Mediators. This invention was developed by Mathias Gary, Sciavolino Frank C and Lipper Robert. The patent application number is US202619459536 20260126. The patent publication number is US2026..

Tripartite Therapeutics Inc Seeks Patent for Ligand-drug Conjugates

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Tripartite Therapeutics Inc has sought patent for Ligand-drug Conjugates. This invention was developed by Lin Young-sun, Huang Er-yi and Lu Hsueh-yi. The patent application number is US202519407141 20251203. The patent publication number is US20260151497 (A1). International Patent Classification codes ar..

Taiwan Patent Office Releases Seagen Patent Application for Methods of Treating Cancers Using Anti-CD30 Antibody-drug Conjugates

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Taiwan Patent Office has released Seagen patent application for Methods of Treating Cancers Using Anti-CD30 Antibody-drug Conjugates. This invention was developed by Chen Tara L. The patent application number is TW20240141404 20241030. The patent publication number is TW202527996 (A). International Patent Cl..

Inventagelab Inc Files Taiwan Patent Application for Microparticles Comprising Tirzepatide or a Pharmaceutically Acceptable Salt Thereof and Method for Producing the Same

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Inventagelab Inc has filed a patent application for Microparticles Comprising Tirzepatide or a Pharmaceutically Acceptable Salt Thereof and Method for Producing the Same. This invention was developed by Kim Ju-hee and Lee Sang-no. The patent application number is TW20250101196 20250110. The patent publicatio..

Riboscience LLC Seeks Patent for 7-aza Bicyclic Heteroaryl Derivatives as Ectonucleotide Pyrophosphatase Phosphodiesterase 1 Inhibitors

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Riboscience LLC has sought patent for 7-aza Bicyclic Heteroaryl Derivatives as Ectonucleotide Pyrophosphatase Phosphodiesterase 1 Inhibitors. This invention was developed by Hawley Ronald. The patent application number is TW20240146274 20241129. The patent publication number is TW202527944 (A). International..

Taiwan Patent Office Publishes Octant Inc Patent Application for Pharmacological Correctors of Rhodopsin and Uses Thereof

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Taiwan Patent Office has published Octant Inc patent application for Pharmacological Correctors of Rhodopsin and Uses Thereof. The invention was developed by Sanzone Jillian R, Jones Eric Matthew, Zheng Tao, Kim Stacie S, Artis Dean Richard, Nisonoff Hunter, Sinz Christopher, Doyon Anna-sophie, Fournier Jean-fr..

Evans David, Noyce Ryan and Lederman Seth Submit Taiwan Patent Application for Synthetic Chimeric Poxviruses

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Evans David, Noyce Ryan and Lederman Seth have submitted a patent application for Synthetic Chimeric Poxviruses. The patent application number is TW20240144133 20171102. The patent publication number is TW202528334 (A). International Patent Classification codes are A61K39/275, A61P31/12 and C07K14/065. Coope..

Memorial Sloan Kettering Cancer Center, Sloan Kettering Inst For Cancer Research and Memorial Hospital For Cancer And Allied Diseases Submit Patent Application for Combination Inhi..

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Memorial Sloan Kettering Cancer Center, Sloan Kettering Inst For Cancer Research and Memorial Hospital For Cancer And Allied Diseases have submitted a patent application for Combination Inhibitors for Treating Fibrosis. Thompson Craig B and Schwoerer Simon developed the invention. The patent application ..

Alkermes Inc Submits Patent Application for Compound for Use in Treating Narcolepsy

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Alkermes Inc has submitted a patent application for Compound for Use in Treating Narcolepsy. Rege Bhaskar M, Landry Ishani Savant, Berellini Giuliano and Kharidia Jahnavi developed the invention. The patent application number is TW20240140017 20241021. The patent publication number is TW202527911 (A). Intern..

Taiwan Patent Office Publishes Biomedical Res Group Inc and Macrophi Inc Patent Application for Lipopolysaccharide, Lipopolysaccharide Production Method, and Lipopolysaccharide Com..

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Taiwan Patent Office has published Biomedical Res Group Inc and Macrophi Inc patent application for Lipopolysaccharide, Lipopolysaccharide Production Method, and Lipopolysaccharide Composition. The invention was developed by Soma Gen-ichiro, Inagawa Hiroyuki, Kohchi Chie, Sakano Yuka and Ohike Masaki. The pa..

Bo Hui Biotech Co Ltd Files Taiwan Patent Application for Pharmaceutical Formulation Including Enriched Cell Population and Use Thereof

Pharmaceutical

| Tue 09 Jun 2026

Taipei, June 9 -- Bo Hui Biotech Co Ltd has filed a patent application for Pharmaceutical Formulation Including Enriched Cell Population and Use Thereof. This invention was developed by Kuo Ching-yao. The patent application number is TW20230151761 20231231. The patent publication number is TW202528537 (A). International Paten..

Memorial Sloan Kettering Cancer Center and Cancer Research Technology Apply for Patent on Tumour Stratification for Responsiveness to an Immune Checkpoint Inhibitor

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Memorial Sloan Kettering Cancer Center and Cancer Research Technology have applied United States patent for Tumour Stratification for Responsiveness to an Immune Checkpoint Inhibitor. Gammage Payam and Reznik Eduard developed it. The patent application number is US202419123257 20241024. The patent public..

Nonexomics Inc Seeks Patent for Compositions and Methods for Treatment of Cancer

Pharmaceutical

| Mon 08 Jun 2026

Alexandria, June 9 -- Nonexomics Inc has sought patent for Compositions and Methods for Treatment of Cancer. This invention was developed by Chauhan Ruchi and Prabakaran Sudhakaran. The patent application number is US202318875017 20230615. The patent publication number is US20260152745 (A1). International Patent Classificatio..

Nanjing Keluosi Biotechnology Co Ltd Submits Chinese Patent Application for Method for Identifying Covalent Target Spot of Antitumor Drug and Application of Covalent Target Spot

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Nanjing Keluosi Biotechnology Co Ltd has submitted a patent application for Method for Identifying Covalent Target Spot of Antitumor Drug and Application of Covalent Target Spot. This invention was developed by Gong Xue, Liu Biwei and Chen Nan. The patent application number is CN202511716804 20251121. The p..

Yue Yaofeng Applies for Patent on Method for Efficiently Screening ATP Hydrolase Antibody Based on Fluorescent Probe

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Yue Yaofeng has applied Chinese patent for Method for Efficiently Screening ATP Hydrolase Antibody Based on Fluorescent Probe. The patent application number is CN202511470362 20251015. The patent publication number is CN121559077 (A). International Patent Classification codes are A61K39/395, A61P35/00, A61..

State Intellectual Property Office of China Publishes Guangzhou Jinmanli Pharmaceutical Tech Co Ltd Patent Application for Method and System for Detecting Cd38 Antibody Drug Recept..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Guangzhou Jinmanli Pharmaceutical Tech Co Ltd patent application for Method and System for Detecting Cd38 Antibody Drug Receptor Occupation. The invention was developed by Zhao Zhanran, Su Xue, Huang Jianqing and Hu Yan. The patent application number..

State Intellectual Property Office of China Publishes Sichuan Neo Green Pharmaceutical Technology Development Co Ltd Patent Application for Thin-layer Method for Identifying Honey ..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Sichuan Neo Green Pharmaceutical Technology Development Co Ltd patent application for Thin-layer Method for Identifying Honey Inula Herb Traditional Chinese Medicine Formula Granules and Inula Herb Traditional Chinese Medicine Formula Granules and Prepa..

State Intellectual Property Office of China Releases Xinjiang Huachun Biological Pharmaceutical Patent Application for Thin-layer Analysis Method for Flavonoid Compounds in Humulus..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has released Xinjiang Huachun Biological Pharmaceutical patent application for Thin-layer Analysis Method for Flavonoid Compounds in Humulus Lupulus. This invention was developed by Li Chenggong, Wang Lei, Wang Fanhong, Chen Mo, Li Zhen, Dong Huijuan and Cai Li. The..

State Intellectual Property Office of China Releases Wuxi Jiyu Shanhe Pharmaceutical Co Ltd Patent Application for Method for Detecting Wrapped Drug and Free Drug in In-vivo Liposo..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has released Wuxi Jiyu Shanhe Pharmaceutical Co Ltd patent application for Method for Detecting Wrapped Drug and Free Drug in In-vivo Liposome. This invention was developed by Wu Sunyi and Zhang Xiaojuan. The patent application number is CN202511996737 20251227. T..

State Intellectual Property Office of China Publishes Shandong Anhong Pharmaceutical Co Ltd Patent Application for Method for Detecting Beta-lactam Compound Residues in Medicine

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Shandong Anhong Pharmaceutical Co Ltd patent application for Method for Detecting Beta-lactam Compound Residues in Medicine. The invention was developed by Li Yufeng, Li Tao, Li Zhen, Zheng Wenfeng, Guan Qinglei, Yan Min and Fu Jinglong. The patent a..

Chengdu Anlite Pharmaceutical Tech Co Ltd Files Chinese Patent Application for Method for Detecting Content of Glyceryl Monostearate and Glyceryl Distearate in Cream

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Chengdu Anlite Pharmaceutical Tech Co Ltd has filed a patent application for Method for Detecting Content of Glyceryl Monostearate and Glyceryl Distearate in Cream. This invention was developed by Li Pei, Liu Xiang, Zhou Tiantian, Wang Dong, Jiang Lufei, Pu Lijuan and Feng Yujuan. The patent application num..

State Intellectual Property Office of China Receives Yuanda Wuyao Jiangsu Pharmaceutical Co Ltd Patent Application for Method for Detecting Related Substances in Pemebenzoic Acid b..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has received Yuanda Wuyao Jiangsu Pharmaceutical Co Ltd patent application for Method for Detecting Related Substances in Pemebenzoic Acid by Hplc (high Performance Liquid Chromatography) Method. Liu Mengting, Yu Fan, Wang Yuan and Jia Wenjuan developed the invention..

Shantou Mebo Pharmaceuticals Co Ltd Submits Patent Application for Method for Constructing Fingerprint Spectrum of Relevant Characteristic Peaks of Rhizoma Coptidis Paste and Radix..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- Shantou Mebo Pharmaceuticals Co Ltd has submitted a patent application for Method for Constructing Fingerprint Spectrum of Relevant Characteristic Peaks of Rhizoma Coptidis Paste and Radix Rehmanniae Recen. Yin Zhaorui, Yu Yang and Fan Keqing developed the invention. The patent application number is CN20251..

State Intellectual Property Office of China Publishes Guangxi Zhuang Autonomous Region Veterinary Drug Supervision Institute and Zibo Wellcell Biotechnology Patent Application for ..

Pharmaceutical

| Tue 09 Jun 2026

Beijing, June 9 -- State Intellectual Property Office of China has published Guangxi Zhuang Autonomous Region Veterinary Drug Supervision Institute and Zibo Wellcell Biotechnology patent application for Method for Simultaneously Detecting Multiple Drug Residues in Buffalo Milk. The invention was developed by Li Wenjing, Chen Fan..

1 to 100 of 1609 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles